Sabra Healthcare REIT, Inc.

SBRA Real Estate Reit Healthcare Facilities

Sabra Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $774.6 million, up 10.2% from fiscal 2024.

Revenue
+31.3%
EPS
+24.1%
Free cash flow
+26.7%
Total debt
−5.99%

Quarter to September 2026, against a year earlier

21.05 0.16 +0.77%
Market cap
$5.5B
P/E
74.7×
Fwd P/E
48.8×
Dividend yield
5.70%
F-score
5/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

Sabra Healthcare REIT, Inc. (SBRA) Price to free cash flow

Alert me on Price to free cash flow

Sabra Healthcare REIT, Inc. has no meaningful price to free cash flow: its trailing twelve-month free cash flow is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 63.1× (November 2025) — the current reading is the lowest in ten years.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 0.0× —
FY2024 18.8× 120.22%
FY2023 8.5× (24.95%)
FY2022 11.4× 20.64%
FY2021 9.4× (39.20%)
FY2020 15.5× 142.30%
FY2019 6.4× (1.27%)
FY2018 6.5× —
FY2017 0.0× —
FY2016 13.5× —

Quarterly newest first

Period Price to free cash flow Change
Sep 2026 0.0× —
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
43 more quarters

Against its own ten years

Low 0.0× High 63.1×
Ten-year median 8.3×
Current reading's percentile 28

Price to free cash flow against peers

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on SBRA